INTRODUCTION
Colorectal cancer (CRC) is one of the most common cancers worldwide. Of all gut malignancies, it has the highest chance of curability as long as it is detected at an early stage -either as a premalignant lesion or before lymph node metastasis. In European national screening programs, approximately 17% of cancers detected were pT1 CRCs, and the risk of developing advanced neoplasia following polypectomy was esti mated at 0.6% [1] . Most reports focus on sessile or flat lesions of the colorectum, while few studies discuss the management of pedunculated cancer precursor lesions. Studies often combine data for both sessile and pedunculated polyps. Moreover, submucosal invasion is presented in the literature as absolute depth, disregarding the presence of the stalk [2] , resulting in further bias. In particular, describing the macroscopic appearance of pedunculated lesions and the final histopathological diagnosis often remain challenging. At first sight, pedunculated lesions can easily be treated endoscopically; however, no large scale reports exist to establish the real risk of lymph node metastasis stratified by depth of invasion. Addi tionally, an adequate technique for complete resection is mandatory for curative intent, providing the best longterm outcome. In this respect, a discussion regard ing the diagnosis of malignancy inside pedunculated, separate from nonpedunculated, polyps is necessary. A clear distinction between head and stalk invasion of malignant cells is also required.
LITERATURE SEARCH
The aim of this article was to address strategies for diagnosis, staging, and risk stratification of patients with malignant pedunculated colorectal polyps (MPCP), as well as to provide a critical review of the literature regarding their management, to summarize their current state and to consider future perspectives. The literature search was conducted with PubMed and included full text articles, uptodate guidelines and recent abstracts with obvious conclusions as well as additional relevant publications by using the reference lists of the identified articles as a starting point. The following keywords were used: "pedunculated colorectal polyps", "malignant colorectal polyp", "early CRC", "polypoid early colon cancer", "early diagnosis", "staging", and "depth of invasion", alone or in various combinations.
DEFINITIONS, CLASSIFICATIONS

AND HISTOPATHOLOGICAL CHARACTERISTICS
By definition, a malignant polyp -either sessile or pedunculated, consists of cancer cells that invade the submucosa through the muscularis mucosae without crossing the submucosa, regardless of lymph node status and without distant metastasis (T1NxMo) [3] . The term "early colorectal carcinoma" can also be used [4] . An advanced adenoma is defined as a lesion of at least 10 mm with villous components or highgrade dysplasia [5, 6] . Currently, "highgrade dysplasia" is a term used for adenomas in which there is mucosal invasion without extension below the muscularis mucosae [7] . According to the recommendations of the World He alth Organization (WHO), this term is preferable to "intramucosal carcinoma" [7, 8] . The reason is that focal cancer that has not yet invaded through the muscularis mucosae is considered to have no risk of spreading to the lymph nodes because no lymphatic channels are located superficially to the muscularis mucosae [7] . The patients in this situation are considered to be safe candidates for endoscopic resection.
Pedunculated polyps are recognized by their stalk of variable lengths that is attached to the colonic mucosa [9] . They are described endoscopically in the Paris international classification as 0Ip lesions. Although it has been reported to anticipate highgrade dysplasia and even invasive carcinoma, interobserver variability associated with the Paris classification has not been studied [10] . Class 5 of Kudo's pit pattern classification, characterized by an unstructured or excavated surface, demarcated depressed areas, loss of lobulation and stalk swelling, has been shown to correlate with the diagnosis of malignancy [11, 12] . A large multicenter cohort study emphasized the difficult diagnosis, as there has been a lack of agreement on the diagnosis of MPCP in a high percentage of cases [13] .
The level of invasion of the stalk further dictates management, from a minimally invasive endoscopy to an invasive surgical resection. MPCP should be di scussed separately from nonpedunculated polyps to obtain accurate conclusions. If in the case of a sessile polyp, the cancer cells travel a short distance to become invasive and metastatic, should the stalk length be considered a favorable prognostic factor as a first barrier through the advanced cancer pathway?
Haggitt et al [14] classified the level of invasion in a pedunculated malignant polyp as follows: Level 1: invasive adenocarcinoma limited to the polyp head (invading through the muscularis mucosae); 
FACTORS PREDICTING LYMPH NODE STATUS IN MALIGNANT
PEDUNCULATED COLORECTAL POLYPS
Even if pedunculated polyps are generally considered to have fewer lymph node metastases, variable mor phology and length of the stalk can lead to problematic measurement of the depth of the submucosal invasion and to further controversies (Table 1) . In a recent systematic review and metaanalysis of histopathological factors influencing the risk of lymph node metastasis in early CRC [2] , a separate analysis of pedunculated polyps from sessile tumors was not possible because of insufficient data. They concluded that in early CRC, a depth of invasion of more than 1 mm in the submucosa by the primary tumor, poorly diff erentiated cancers, the presence of tumor budding and lymphovascular invasion were significantly associated with lymph node involvement.
Moreover, Kitajima et al [15] previously found a rate of lymph node metastasis of zero in head invasion cases (the deepest portion of invasion limited to above the baseline) and in stalk invasion cases with a depth of submucosal invasion < 3000 μm (MPCP with the level 2 line according to Haggitt's classification used as the baseline and depth of submucosal invasion measured to the deepest portion in the submucosa).
In a large retrospective cohort study [16] , the authors concluded that MPCP diagnosed as head invasion by the pathologist can be safely treated by endoscopic polypectomy alone. They included 383 patients with pathologically proven adenocarcinoma spread throu gh the muscularis mucosae into the submucosa but without extension to the muscularis propria. The inva sion depth was classified into two groups by using the upper limit of level 2 according to Haggitt's classification as the baseline for all lesions. When an endoscopy was suggestive of submucosal invasion into the polyp stalk, those patients were managed directly by surgery with lymph node dissection. Thus, they found a lymph node involvement rate and recurrence rate of 3.5% (8/230; 95%CI: 1.5%-6.7%) and 0.3% (1/340; 95%CI: 0.01%-1.6%), respectively. The incidence of metastasis to the lymph nodes and recurrence rate were 0% (0/101; 95%CI: 0.0%-3.6%) and 0%, respectively, (0/219; 95%CI: 0.0%-1.7%) for the lesions with head invasion, compared with 6.2% (8/129; 95%CI: 2.7%-11.9%) and 0.8% (1/121; 95%CI: 0.02%-4.50%), respectively, for stalk invasion. A total of 29% of lesions with head invasion were lymphovascular invasion positive, while 38% of stalk invasion lesions were lymphovascular invasion positive. Finally, the authors noted no significant difference in any other factors (such as tumor size, tumor differentiation grades, or even lymphovascular invasion) except for the depth of invasion (stalk invasion) between lymph node metastasis positive and negative groups.
In a previous study on 151 patients with colorectal polyps that included invasive carcinoma treated by resection, Nivatvongs et al [17] concluded that, unlike tumor size and grading, only the depth of invasion to the base of the stalk (Level 4) was associated with a high risk of lymph node metastasis (27%).
On the other hand, in another approach with patients who underwent systematic lymph node dissection, metastasis was observed in 14.6% of cases, and multi variate analysis showed that tumor budding was the only independent factor associated with lymph node metastasis [18] . Interestingly, Kimura et al [19] recently suggested that head invasion is not a lymph node metastasisfree condition in a study on 76 pedunculated polyps with no significant differences in the lymph node metastasis rate between "head invasion" (4/30, 13.3%) and "stalk invasion" (5/46, 10.9%). They stated that even for MPCP with "head invasion", additional surgical resection with lymph node dissection should be taken into consideration if there are other risk factors. Indeed, the detection of tumor buds has been re ported as an indication for colorectal surgery because of the high risk for lymph node metastasis. Pathologically, tumor budding is defined as single tumor cells or small clusters of four or fewer tumor cells in the tumor stroma, at the invasive front and in malignant polyps [20, 21] . Wide spread reporting of tumor budding has been limited in daily diagnostic practice due to a lack of consensus regarding guidelines on scoring methods [20, 21] . Although some authors [8, 22] consider it important that at least highgrade tumor budding (more than 10 tumor buds in any microscopic field viewed at 25X) should be recorded in the pathology report as a prognostic factor. Invasive micropapillary carcinoma is composed of small clusters of tumor cells lying within clear stromal spaces simulating vascular channels [23, 24] and is con sidered to be related to a high incidence of lymph node metastasis. However, its actual prevalence among early CRCs has not been reported [25, 26] , as a limited number of cases are reported in the literature. Similar cases of pedunculated early sigmoid colon cancer with a micropapillary component and multiple lymph node metastases were reported by Sonoo et al [26] , Verdú et al [27] and by Mukai et al [28] . In another case of a sigmoid pedunculated polyp with a depressed surface without evidence of lymph node involvement or distant metastases on initial computed tomographic scans, the patient had local recurrence with lymph node metastases but also lung, liver, and spleen metastases at 6 months followup after the polypectomy [29] . Therefore, even if the initial diagnosis is an MPCP, extensive surgical resection may still be taken into consideration for tumors with a micropapillary component due to the high risk for lymph node metastasis and poor outcome.
Beyond the conclusions of these studies, immuno histochemistry for the confirmation of the difficultto assess lymphovascular invasion is usually reserved for equivocal cases (e.g., tumors with positive margins after resection) [30] . Chickenskinlike mucosa is an endoscopic finding described as pale yellowspeckled mucosa frequently surrounding pedunculated adenomas of the distal colon. Its clinical and pathophysiological significance have yet to be determined. Histopathologically, it represents fat accumulation in macrophages within the muscularis propria and, rarely, intestinelike microvilli. In two studies [31, 32] , the prevalence of chickenskinlike mucosa was higher in carcinoma patients than in adenoma patients, and its role as a potential predictive marker of carcinogenetic progression was taken into consideration. However, it is a colonoscopic sign to search for a polyp in challenging locations. Additionally, it may serve as a potential marker of advanced pathology of colorectal adenoma in future research and might offer a better perspective on postpolypectomy management [33] . Both endoscopists and histopathologists should also pay attention to possible pseudoinvasion. A histo pathological pseudoinvasion (prolapse of the adeno matous epithelium into the polyp stalk), associated with ischemic changes when the polyp stalk is twisted, can be observed more often in large pedunculated polyps, which are typically located in the sigmoid colon and rarely in the rectum [7] . Despite the lack of a gold standard diagnosis, invasive carcinoma could be distinguished from pseudoinvasion by the presence of stromal desmoplasia and highgrade dysplasia [34] . However, the exact incidence of discordant diagnosis cannot be estimated; moreover, misplaced epithelium in pedunculated polyps has a lobular contour with a rim of lamina propria, along with hemorrhage, and/or hemo siderin [35] . Biopsyrelated misplacement can be even more difficult to recognize than typical pseudoinvasion in polyps with stalks [36] . Thus, because misplaced epithelium can simulate early CRC in pedunculated polyps, British guidelines currently recommend diagnostic confirmation of T1 CRC by a second expert pathologist [13] .
CHALLENGES IN ENDOSCOPIC RESECTION TECHNIQUES
When we suspect a malignant pedunculated polyp, the snare should be placed as close as possible to the bowel wall to increase the chance of obtaining a cancer free resection margin. Snare polypectomy is considered LNM: Lymph node metastases. Depth of invasion in submucosa by the primary tumor of more than 1mm (Beaton et al [2] ) High Surgery with lymph node dissection Poorly differentiated cancers (Beaton et al [2] )
Tumor budding (Beaton et al [2] , Sohn et al [18] , Geramizadeh et al [7] , Graham et al [22] ) Lymphovascular invasion (Beaton et al [2] )
Depth of invasion to the base of the stalk-Level 4 Haggitt (Nivatvongs et al [17] , Kimura et al [19] )
Submucosal invasion into the polyp stalk (Matsuda et al [16] )
Micropapillary component (Sonoo et al [26] , by Verdú et al [27] , Mukai et al [28] )
Head invasion (Kimura et al [19] ) Surgical resection with lymph node dissection in case of additional pathological risk factors Head invasion (Kitajima et al [15] , Matsuda et al [16] ) Low Endoscopic polypectomy Depth of submucosal invasion/stalk invasion < 3000 μm (Kitajima et al [15] )
Tumor size (Nivatvongs et al [17] )
Grading (Nivatvongs et al [17] )
Pseudoinvasion (Backes et al [13] ) Confirmation of t1 colorectal cancer by a second expert pathologist curative when the histopathology report is favorable, but there is no consensus on the accurate assessment of negative margins. Most authors [37, 38] consider polypectomy technically satisfactory, with the lowest rate of local recurrence and metastases, if the margin from the invasive component to the diathermy burn is at least 2 mm. A new study [39] reported a similar 5 year cumulative recurrence rate between surgical and endoscopic resection (8.2% and 2.4%, respectively) for patients with MPCP and a pathological margin ≥ 1 mm. The site of resection should be inked with a tattoo to facilitate easy recognition if surgery is necessary; however, there is no guideline on the optimal placement of tattoos or metallic clips [40] . Unlike sessile or flat polyps, in the case of pe dunculated lesions, it is easier for the pathologist to avoid a diathermy artifact of the resected specimen and to better identify eventual invasive cancer cells at the polypectomy margin due to the distance of resection from the invasive component. Many studies [16, 41] have stated that pedunculated early polyp CRCs limited to the polyp head, without unfavorable histological features, could be managed by endoscopic resection alone with minimal risk of locoregional recurrence. However, in cases of unfavorable histological criteria (resection margins less than 1 mm, poor differentiation, lymphovascular invasion, invading the submucosa of the bowel wall below the stalk), endoscopy is not considered curative; therefore, surgery is recommended [40] . Generally, giant pedunculated polyps (over 30 mm) have been managed surgically; further prospective studies are needed to establish if endoscopic resection of giant MPCP represents a feasible safe procedure [42] . Recently, a prospective pilot study explored the sa fety and feasibility of insulatedtip knife endoscopic polypectomy for difficult giant polyps [43] . Endoscopic submucosal dissection [44] and the use of a dual knife procedure [45] were reported to be options as well, but the patient number was too small to make definitive conclusions. Pedunculated polyps have a higher risk of bleeding compared to sessile polyps [46] . Postpolypectomy blee ding is the most common complication reported in the literature, and the rate varies between 24% [47] and the more usual frequency of 3%-4% [48] . When considering referral bias, the general frequency is thought to be lower, while other complications such as postcoagulation syndrome or perforation can rarely occur [49] . The only polyprelated factor that has been constantly proven to increase the risk of delayed bleeding is the large size of the lesion [50, 51] . Therefore, pretreatment of stalks in large polyps may be necessary, and a variety of techniques are available. For polyps with a head ≥ 20 mm or a stalk ≥ 10 mm in diameter, recent European guidelines (ESGE) have recommend pretreatment of the stalk with injection of diluted adrenaline and/or mechanical hemostasis (moderate quality evidence, strong recommendation) [52] .
Endoclips
Prophylactic clipping before or after polypectomy re mains controversial, with conflicting results reported in different studies [46] . Quintanilla et al [53] reported in a prospective ran domized study of large pedunculated polyps that prophylactic clips (prior to polyp resection) did not de crease the risk of delayed bleeding after polypectomy. Technically, they suggested the use of hemoclips in the case of polyps with long and thin pedicles. However, this study was suspended early because of the high risk of morbidity in the clipping group, with higher rates of mucosal burns and perforation rather than bleeding. Very thick and/or short stalks may be a challenge for clip placing, causing mucosal burns and risk of perforation due to the contact of the base of the polyp with the snare and the clip [54] . Indeed, prophylactic clips applied before endoscopic removal for this type of polyps were actually asso ciated with further risk of mucosal deep erosions and perforation [55] . For MPCP resected by hot snaring, neither early nor delayed bleeding complications occurred for more than two decades during which clips were not used [56] . On the other hand, Parikh et al [57] concluded that prophylactic placement of hemoclips after polypectomy was a costeffective plan for patients on antiplatelet or anticoagulation therapy.
Endoloops
The use of the endoloop can also generate technical difficulties from looping large polyps and the endoloop removal [53] to the transection by the loop of a thin stalk before the polypectomy or insufficient tightening of the loop [58] . A prospective randomized multicenter study [59] suggested that the application of a prophylactic hemoclip is as effective and safe as an endoloop in the prevention of postpolypectomy bleeding in large pedunculated colonic polyps.
Anchor clip technique
Mizukami et al [60] described the anchor clip device, which, placed before the resection of large polyps, constrains the base of the stalk after resection, avoiding immediate bleeding and mucosal burns.
Adrenaline injection
A prospective study on pedunculated polyps larger than 20 mm has shown that there are no differences between adrenaline injection and the use of endoloops or hemoclips in postpolypectomy bleeding prophylaxis [48] , although its addition to both techniques appeared to increase the efficiency in other studies [61, 62] . Recently, a prospective randomized study [63] that compared the rates of bleeding after resection following single clipping alone and a combined method (hemoclips plus epinephrine saline injection) concluded that large pedunculated polyps can be successfully removed via hot snare by using the single prophylactic clipping method. A recent metaanalysis of three randomized controlled studies [64] that compared the efficacy of epinephrine injection and mechanical hemostasis in postpolypectomy bleeding in patients with pedunculated polyps over 20 mm demonstrated that prophylactic treatment with mechanical hemostasis is more effective than epinephrine injection for preventing overall postpolypectomy bleeding (2.2% vs 6.3%) and early postpolypectomy bleeding (1.1% vs 4.5%). The rate of delayed postpolypectomy bleeding was 1.9% in the epinephrine group and 1.1% in the mechanical group, and their implementation was not found to significantly affect the rate of delayed postpolypectomy bleeding (OR = 0.58, 95%CI: 0.13, 2.49; p = 0.46) without significant heterogeneity between the studies (p = 0.94, I 2 = 0%).
The impact of underlying comorbidities and other pedunculated polyp characteristics
The presence of comorbidity, beyond the size and loca tion of the polyp, should also be taken into consideration when discussing further management. Different risk factors for postpolypectomy com plications, such as old age (older than 65 years of age), underlying diseases (cardiovascular or chronic renal disease), anticoagulant use, polyp size > 10 mm, a stalk size > 5 mm, polyps located on the right side of the colon, malignant polyps, use of cutting mode and lowvolume endoscopists, have been described [47, 6467] . A recently published review and metaanalysis [68] identified cardiovascular disease, hypertension, polyp size over 10 mm, and polyp location as significant risk factors for delayed postpolypectomy bleeding, whereas pedunculated morphology, carcinoma histology, age, sex, alcohol use, smoking, diabetes and cerebrovascular disease were not.
Related to the polyp location, recent evidence [50] suggests that rightsided polyps have a significantly higher risk of bleeding and perforation in comparison with leftsided polyps, for both sessile and pedunculated polyps.
In conclusion, the effectiveness of common preven tive methods is variable, and no consensus has been reached to date on the strategy to avoid postpoly pectomy bleeding. Large randomized controlled trials are necessary to confirm these observations, taking into consideration more potential risk factors such as pedunculated polyp characteristics (e.g., length of the pedicle) or other patient comorbidities (e.g., the bleeding risk from heparin-bridging therapy in patients with high thromboembolic risk [69] ). Intere stingly, Shibuya et al [70] showed that the overall post polypectomy bleeding rate under the new Japanese guidelines, which indicate that antithrombotic agents are not to be discontinued in cases with a highrisk of thromboembolic incidents, was not significantly higher when compared with data from previous guidelines, without particularly addressing pedunculated polyps.
STRATEGIES FOR PATIENTS ON ANTIPLATELET THERAPY OR ANTICOAGULANTS
The risk of bleeding, as the most common adverse effect of polypectomy and particularly the higher risk of bleeding of pedunculated polyps, was already described in the section "Challenges in endoscopic resection techniques". Therefore, endoscopic polypectomy is considered to be a highrisk procedure based on the risk of bleeding, which is increased by the addition of antiplatelet or anticoagulant therapy. In this group of patients, the risk of hemorrhage should be balanced against the risk of thrombosis when antiplatelet or anticoagulant therapy is discontinued.
Patients with MPCP and indication of polypectomy should be managed as summarized in Table 2 , according to the most recent British Society of Gastroenterology and ESGE general recommendations [71] .
ADEQUATE FOLLOW-UP AFTER
RESECTION
Discussing surveillance after polypectomy can be challenging because the risks and outcomes are difficult to calculate. Generally, when the risk of the lesion seems to be low, interval surveillance is performed. For patients with a higher risk, further surgical resection is necessary, but there is no consensus on followup procedures and subsequent intervals for early cancer in pedunculated lesions. The management of an MPCP following endoscopic resection can generate anxiety for both the physician and patient because of possible residual cancerous cells and/or positive lymph nodes that are variable from one case to another [72] . However, further management remains balanced between the general approach of postpolypectomy surveillance of patients with highrisk adenomas [6, 73, 74] and the follow up of a resected CRC with curative intent [7577] . However, it is also based on the experience and clinical sense of the physician.
The recent recommendations of the United States MultiSociety Task Force on Colorectal Cancer endorsed by the American Society for Gastrointestinal Endoscopy [75] address only the use of colonoscopy in the followup of patients with resected CRC with curative intent and insist on the fact that the colorectum should be carefully cleared of synchronous neoplasia in the perioperative period, without any particular information on early cancer in pedunculated polyps.
Fortunately, pedunculated polyps are unusual in the rectum. However, rectal cancer is generally associated with a higher risk of local recurrence than other segments of the colon, and additional considerations for surveillance [77] , such as endoscopic ultrasound for better detection of suspicious lymph nodes and recurrences [75] , are suggested. The utility of adjuvant chemoradiation or chemoradiation alone for highrisk early rectal carcinoma remains to be elucidated [1] .
In a longterm prospective study of 25 consecutive patients with MPCP treated with snare cautery polypectomy [56] , the author concluded that shortterm outcomes after removal appeared to be similar to those with a nonmalignant polyp. He suggested that longterm surveillance should be considered in each patient, assuming reasonable life expectancy, because the risk of additional adenomas and metachronous colon cancer persists even after the initial five years of currently recommended surveillance.
In addition to the small number of patients, the location of the lesions was limited to the sigmoid or descending colon, and both standard and high-definition colonoscopes were used without calculating the accuracy of polyp detection in separate subgroups. Personal or family history of intestinal neoplasia (such as previously resected adenomas) or underlying inflammatory bowel disease was excluded from the study.
A high carcinoembryonic antigen (CEA) value may be predictive of metastatic disease [7880] . There have been reported cases of MPCP with unfavorable histological criteria without initial local residual carcinoma or lymph node invasion but with distant metastasis even five years after surgery [11, 81] , so close monitoring of such patients using CEA and imaging techniques seems prudent. To our knowledge, to date, there are no particular guidelines including optimal treatment and surveillance of subgroups, such as synchronous CRCs, malignant pedunculated polyps, multiple malignant pedunculated polyps or malignant pedunculated polyps, associated with chronic inflammatory bowel disease.
UNRESOLVED ISSUES AND AREAS FOR FURTHER RESEARCH
There is a thin line between early cancer in pedunculated polyps and invasive cancer, due either to interobserver variation in detection rate by endoscopists or histologic interpretation by pathologists. Standard snare polypectomy is appropriate for pedunculated polyps with early cancer limited to the submucosa and favorable histology. The distance from the cancer to the margin of the resection excision is still under debate. These situations lead to a challenging evaluation of the natural history of the lesions. Treatment plans and the best strategy to avoid postpolypectomy complications for colorectal malignant pedunculated polyps lack the evidence of randomized trials.
Large randomized trials on this particular topic should be included in metaanalyses that develop further guidelines to provide relevant conclusions for patients' longterm Prosthetic heart valve and atrial fibrillation Bare metal coronary artery stents within 1 mo of placement. The last dose of DOAC should be taken at least 48 h before the procedure (very low quality evidence, strong recommendation)
Discontinuing warfarin 5 d before the procedure (high quality evidence, strong recommendation)
Atrial fibrillation and mitral stenosis
Ensure the INR target < 1.5 prior to the procedure (low quality evidence, strong recommendation) < 3 mo after venous thromboembolism Table 2 Endoscopic polypectomy in patients on antiplatelet therapy or anticoagulants (British Society of Gastroenterology and European Society of Gastrointestinal Endoscopy Recommendations [71] ) LMWH: Low molecular weight heparin; DOAC: Direct oral anticoagulants.
surveillance and outcomes. More longterm information focused on patients with endoscopically removed malignant polyps, including personal or family history of intestinal neoplasia, previously resected adenomas, or underlying inflammatory bowel disease [82, 83] , would be valuable.
In addition to general unfavorable histological criteria, better stratification of patients with highrisk pedun culated polyps requiring surgery [84] , including those with highgrade tumor budding or invasive micropapillary components as reliable predictors of lymphohematic metastases, is necessary. On the other hand, inadequate recognition of the pseudoinvasion pitfall as a benign condition can generate overdiagnosis and subsequent overtreatment of certain lesions. In this respect, a second histological opinion seems advisable for all cases of MPCP, especially when surgery is taken into consideration.
CONCLUSION
There are still unresolved issues requiring detailed recommendations according to the patient's and polyp's risk factors to avoid an overuse of surveillance procedures. Provided future novel imaging technologies and increased pathological recognition of highrisk markers for angiolymphatic invasion will be developed, it will be easier to decide on the optimal followup plan and therapy.
